Day: March 15, 2024

<div>Host Hotels & Resorts Announces First Quarter 2024 Earnings Call to be Held on May 2, 2024</div>

Host Hotels & Resorts Announces First Quarter 2024 Earnings Call to be Held on May 2, 2024

BETHESDA, Md., March 15, 2024 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust, will report first quarter 2024 financial results on Wednesday, May 1, 2024, after the market close. The Company will hold a conference call to discuss its first quarter 2024 results and business outlook on Thursday, May 2, 2024, at 11:00 a.m. ET. Conference call access information is as follows: Conference Call: USA Toll Free Number 877-545-0523 International Toll Number 973-528-0016 Access Code 638190     A simultaneous webcast of the call will be available on the Company’s website at www.hosthotels.com. A replay of the call will be available Thursday, May 2, 2024, until Saturday, June 1, 2024, via the telephone details below or via webcast on the...

Continue reading

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on March 11, 2024, it received two letters from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”), one notifying the Company (the “MVLS Notice”) that for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “Market Value Standard”), and the other notifying the Company (the “MVPHS Notice”) that for the last 30 consecutive business days, the Company’s Market Value of Publicly Held Shares (“MVPHS”) was below the minimum of $15 million required for continued listing on the Nasdaq Global Market pursuant...

Continue reading

Coherent Debuts Extended C+L-Band Grisms With Unmatched Efficiency and Performance

Coherent Debuts Extended C+L-Band Grisms With Unmatched Efficiency and Performance

Coherent’s extended C+L-band grism Coherent introduces high-efficiency grisms and transmission gratings capable of encompassing the entire extended C+L band in a single optic. PITTSBURGH, March 15, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a leader in optical communications components and subsystems, has introduced a groundbreaking family of advanced, aberration-correcting, high-efficiency grisms and transmission gratings capable of encompassing the entire extended C+L band in a single optic. These enable construction of more cost-effective, efficient, and compact network components that support more communication channels, such as wavelength selective switches (WSS) and optical channel monitors. “Both the datacom and telecom segments are experiencing a surge in network traffic driven by the adoption of...

Continue reading

Globus Maritime Announces Filing of its 2023 Annual Report on Form 20–F

Globus Maritime Announces Filing of its 2023 Annual Report on Form 20–F

GLYFADA, Greece, March 15, 2024 (GLOBE NEWSWIRE) — Globus Maritime Limited (“Globus,” the “Company,” “we,” or “our”), (NASDAQ: GLBS), a dry bulk shipping company, announced today that the Company’s annual report on Form 20-F that contains the Company’s audited financial statements for the fiscal year ended December 31, 2023 was filed today with the Securities and Exchange Commission, and may be found on the Company’s website at www.globusmaritime.gr under Investor Relations. Alternatively, shareholders may receive a hard copy of the 2023 Annual Report on Form 20-F, free of charge, by request to Globus’ Investor Relations Advisor at: Capital Link Inc.230 Park Avenue, Suite 1540New York, NY 10169 USATel: (+) 1 212 661 7566Email: globus@capitallink.com  About Globus Maritime Limited Globus is an integrated dry bulk...

Continue reading

Wearable Devices Announces Full Year 2023 Financial Results and Provides Corporate Update

Wearable Devices Announces Full Year 2023 Financial Results and Provides Corporate Update

2023 Achievements Position Wearable Devices for Growth in 2024 YOKNE’AM ILLIT, Israel, March 15, 2024 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced its financial results for the year ended December 31, 2023. Asher Dahan, Chief Executive Officer and Chairman of the Board of Wearable Devices, commented, “2023 was characterized by strategic capital allocation and the execution of our growth strategy as we successfully completed delivery of our first manufacturing batch of the Mudra Band for Apple Watch, and entered into several partnerships with companies and contractors at the forefront of their respective industries. Our net loss increased in...

Continue reading

NI Holdings, Inc. Reports Results for Fourth Quarter and Year Ended December 31, 2023

NI Holdings, Inc. Reports Results for Fourth Quarter and Year Ended December 31, 2023

FARGO, N.D., March 15, 2024 (GLOBE NEWSWIRE) — NI Holdings, Inc. (NASDAQ: NODK) announced today results for the year ended December 31, 2023. Summary of Year-End 2023 Results(All comparisons vs. year-end 2022, unless noted otherwise) Direct written premiums of $102.4 million, up 16.2% compared to the prior year quarter and full year direct written premiums of $418.4 million, up 7.4% compared to prior year. Growth in both periods was driven by Non-Standard Auto and Private Passenger Auto. Net earned premiums of $88.6 million, up 4.6% compared to prior year quarter and full year net earned premiums of $351.1 million, up 7.0% compared to prior year. Combined ratio of 85.9%, down 23.5 pts compared to the prior year quarter, driven by improved underwriting results across all segments. Combined ratio of 103.4% for full year 2023 versus...

Continue reading

Paul Mueller Company Announces Its Fourth Quarter Earnings of 2023

Paul Mueller Company Announces Its Fourth Quarter Earnings of 2023

SPRINGFIELD, Mo., March 15, 2024 (GLOBE NEWSWIRE) — Paul Mueller Company (OTC: MUEL) today announced earnings for the quarter ended December 31, 2023.                           PAUL MUELLER COMPANY TWELVE-MONTH REPORT (In thousands) CONSOLIDATED STATEMENTS OF INCOME                               Three Months Ended   Twelve Months Ended     December 31   December 31     2023   2022   2023   2022                           Net Sales   $ 55,786     $ 59,002     $ 229,156     $ 191,520   Cost of Sales   38,744     50,082     158,625     152,286   Gross Profit   $ 17,042     $ 8,920     $ 70,531     $ 39,234   Selling, General and Administrative Expense   51,723     4,679     88,269     35,011   Operating Income (Loss)   $ (34,681 )   $ 4,241     $ (17,738 )   $ 4,223   Interest Expense   (91 )   (87 )   (350 )   (697 ) Other...

Continue reading

Wayne Savings Bancshares, Inc. and Main Street Financial Services Corp. Receive Regulatory Approval for Merger

Wayne Savings Bancshares, Inc. and Main Street Financial Services Corp. Receive Regulatory Approval for Merger

WOOSTER, Ohio and WHEELING, W.Va., March 15, 2024 (GLOBE NEWSWIRE) — Wayne Savings Bancshares, Inc. (OTCQX: WAYN) (“Wayne”), the holding company of Wayne Savings Community Bank and Main Street Financial Services Corp. (OTCPK: MSWV) (“Main Street”), the holding company of Main Street Bank Corp., jointly announced today that approval has been received from the Federal Reserve Bank, The Federal Deposit Insurance Corp., the Ohio Division of Financial Institutions, and the West Virginia Board of Banking and Financial Institutions (collectively, the “Regulatory Authorities”) for the merger of Wayne with and into Main Street followed by the merger of Main Street Bank Corp. with and into Wayne Savings Community Bank. “We are pleased to have received all required approvals from the Regulatory Authorities. We are...

Continue reading

Genius Group to Host Genius Investor Call on 21 March, 2024 Providing Revised Post-merger 2024 Guidance and Roadmap

Genius Group to Host Genius Investor Call on 21 March, 2024 Providing Revised Post-merger 2024 Guidance and Roadmap

SINGAPORE, March 15, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, announces that it will host a Live Virtual investor Call on Thursday, March 21, 2024, with its Chief Executive Officer, Roger Hamilton, and FatBrain AI’s Chief Executive Officer, Peter Ritz. The virtual meeting will be held as a YouTube Livestream, and will include: Post-merger Growth Strategy – Road map to 100 million students goal Genius City Plan – Road map to 100 Genius Cities goal Upgraded AI Product & Partnership – Plan to $1 billion revenue goal Update on legal actions Revised 2024 Financial Guidance A Q&A to answer shareholder enquiries To ensure all enquiries are answered, except those related to legal proceedings that Counsel advises should...

Continue reading

XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps

XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps

ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis patients without nasal polyps Clinical trial program also showed reduction in sinus inflammation and in acute exacerbations, which frequently result in use of antibiotics XHANCE uses the proprietary Exhalation Delivery System to enable deposition of a proven steroid in target areas of inflammation deep in the nose not typically reached by standard nasal sprays Chronic sinusitis affects approximately 30 million adults in the U.S. YARDLEY, Pa., March 15, 2024 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the U.S. Food and Drug Administration (FDA) has approved...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.